Dose intensification of vedolizumab is not effective in inducing endoscopic response in Crohn's disease patients with endoscopic primary non-response

被引：0
|
作者：
Oldenburg, L.
Baert, F.
Bossuyt, P.
Hoentjen, F.
Clasquin, E.
Molnar, T.
Loewenberg, M.
Vermeire, S.
D'Haens, G.
机构：
[1] Univ Amsterdam, Med Ctr, Gastroenterol, Amsterdam, Netherlands
[2] AZ Delta, Gastroenterol, Roeselare, Belgium
[3] Imelda Gen Hosp, Gastroenterol, Bonheiden, Belgium
[4] Univ Alberta, Gastroenterol, Edmonton, AB, Canada
[5] Univ Szeged, Internal Med, Szeged, Hungary
[6] Univ Hosp Leuven, Gastroenterol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0009
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP09
引用
收藏
页码：i17 / i18
页数：2
相关论文
共 50 条
  • [21] MULTI-ALLELES POLYMORPHISMS PREDICT PRIMARY NON-RESPONSE TO INFLIXIMAB THERAPIES IN CROHN'S DISEASE
    Tang, Jian
    Zhang, Caibin
    Gao, Xiang
    GASTROENTEROLOGY, 2019, 156 (06) : S1116 - S1117
  • [22] A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease
    Li, Li
    Chen, Rirong
    Zhang, Yingfan
    Zhou, Gaoshi
    Chen, Baili
    Zeng, Zhirong
    Chen, Minhu
    Zhang, Shenghong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease
    Holmer, Ariela K.
    Battat, Robert
    Dulai, Parambir S.
    Vande Casteele, Niels
    Nguyen, Nghia
    Jain, Anjali
    Miralles, Ara
    Neill, Jennifer
    Le, Helen
    Singh, Siddharth
    Rivera-Nieves, Jesus
    Sandborn, William J.
    Boland, Brigid S.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [24] Genetic Markers Predict Primary Non-Response and Durable Response to Anti-TNF Biologic Therapies in Crohn's Disease
    Barber, Grant E.
    Yajnik, Vijay
    Khalili, Hamed
    Garber, John
    Giallourakis, Comas
    Xavier, Ramnik
    Ananthakrishnan, Ashwin N.
    GASTROENTEROLOGY, 2016, 150 (04) : S387 - S387
  • [25] Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease
    Barber, Grant E.
    Yajnik, Vijay
    Khalili, Hamed
    Giallourakis, Cosmas
    Garber, John
    Xavier, Ramnik
    Ananthakrishnan, Ashwin N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12): : 1816 - 1822
  • [26] Effect of Disease Location on Endoscopic and Radiographic Outcomes in Patients With Moderate to Severe Crohn's Disease Initiated on Vedolizumab
    Kashani, Amir
    Pabla, Baldeep S.
    Eaddy, Andre
    Scoville, Elizabeth
    Dalal, Robin
    Beaulieu, Dawn B.
    Schwartz, David A.
    Horst, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S461 - S461
  • [27] Is endoscopic balloon therapy an effective treatment for patients with Crohn's disease strictures?
    Van Assche, G
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (07): : 298 - 299
  • [28] Is endoscopic balloon therapy an effective treatment for patients with Crohn's disease strictures?
    Gert Van Assche
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 298 - 299
  • [29] Infliximab dose intensification in patients with Crohn's disease
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (11): : 588 - 589
  • [30] The response of Crohn's strictures to endoscopic balloon dilation
    Mueller, T.
    Rieder, B.
    Bechtner, G.
    Pfeiffer, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (06) : 634 - 639
12345